A Ma Shi Sheng Yi Co., Ltd.

阿瑪施生醫股份有限公司　·　Unified Business No. 54172520　(English name romanized by inc.com.tw)

Business ID54172520

Representative葉明功Ye Ming-Gong

CapitalNT$ 600,000,000

Established2013about 13 years ago

Status—

Company Profile

Unified Business No.	54172520
Company Name (Chinese)	阿瑪施生醫股份有限公司
English Name	A Ma Shi Sheng Yi Co., Ltd. romanized by inc.com.tw · no official English name registered
Registration Status	—
Registered Capital	NT$ 600,000,000≈ NT$ 600 million · US$ 19.0M (approx.)
Paid-in Capital	NT$ 37,400,000≈ NT$ 37 million · US$ 1.2M (approx.)
Date of Incorporation	2013-03-15 (about 13 years)
Representative	葉明功 Ye Ming-Gong · romanized by inc.com.tw
Industry	醫學檢驗服務, 其他未分類專業, 科學及技術服務, 其他醫療器材及用品製造, 其他藥品及醫療用品批發 (partly Chinese; machine-assisted translation)
Registered Address	臺北市松山區敦化北路170號14樓 (map)14F, No. 170, Dunhua N. Rd., Songshan Dist., Taipei City · romanized by inc.com.tw

Board of Directors & Supervisors

No.	Title	Name (Chinese)	Romanized	Capital Contribution	Stake
0001	Chairman	葉明功	Ye Ming-Gong	0
0002	Director	光輝生命醫學股份有限公司	Guang Hui-Sheng-Ming-Yi-Xue-Gu-Fen-You-Xian-Gong-Si	2,200,000	58.82%
0003	Director	李光輝	Li Guang-Hui	400,000	10.70%
0004	Director	李光耀	Li Guang-Yao	110,000	2.94%
0005	Director	楊洪平	Yang Hong-Ping	0
0006	Supervisor	易定芳	Yi Ding-Fang	0
0007	Supervisor	李靜枝	Li Jing-Zhi	30,000	0.80%

Stake is estimated (share count × par value NT$10 ÷ paid-in capital for joint-stock companies); names romanized by inc.com.tw.

This English profile is compiled from Taiwan government open data (Ministry of Economic Affairs, Ministry of Finance). Field labels are translated; values such as Chinese names and addresses are shown in their original Chinese. For the full record see the Chinese version.

Add on LINE — check any Taiwan company by chat

Taiwan Company Registry　A free company lookup service aggregating Taiwan government open data

Data is sourced from Taiwan government open-data platforms and provided for reference only; accuracy and timeliness are not guaranteed. For official purposes, please consult the competent authority.